PET and SPECT in low-grade glioma

European Journal of Radiology

Volumn 56, Issue 2, 2005, Pages 171-178

  Minn, Heikki ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Low grade glioma; PET; Radionuclide imaging; SPECT

Indexed keywords

GROWTH (MATERIALS); INTEGRATION; MAGNETIC RESONANCE IMAGING; METABOLISM; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; SCANNING;

LOW-GRADE GLIOMA; NEOPLASMS; RADIONUCLIDE IMAGING; SPECT;

SURGERY;

ANTINEOPLASTIC AGENT; CHOLINE C 11; CYSTEINE ETHYL ESTER TC 99M; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; FLUOROETHYLTYROSINE F 18; FLUOROTHYMIDINE F 18; GADOLINIUM; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; IODINE 123; IODINE 131; IODO ALPHA METHYLTYROSINE I 123; IODODEOXYURIDINE I 124; METHIONINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; OXYGEN 15; RADIOPHARMACEUTICAL AGENT; STEROID; TECHNETIUM 99M; THALLIUM 201; THALLIUM CHLORIDE TL 201; TYROSINE C 11; UNCLASSIFIED DRUG; WATER O 15;

ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; CELL HETEROGENEITY; COMPUTER ASSISTED TOMOGRAPHY; DEVICE; DIAGNOSTIC ACCURACY; DRUG HALF LIFE; FOLLOW UP; GLIOMA; GROWTH RATE; HEALTH CARE COST; HUMAN; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION INJURY; RADIATION NECROSIS; SCANNER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN NEOPLASMS; FOLLOW-UP STUDIES; GLIOMA; HUMANS; PATIENT CARE PLANNING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 26944478895     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2005.03.020     Document Type: Article

References (52)

1. P.E. Ricci, and D.H. Dungan Imaging of low- and intermediate-grade gliomas Semin Radiat Oncol 11 2001 103 112
2. F. Bénard, J. Romsa, and R. Hustinx Imaging gliomas with positron emission tomography and single-photon emission computed tomography Semin Nucl Med 33 2003 148 162
3. M.E. Phelps PET: the merging of biology and imaging into molecular imaging J Nucl Med 41 2000 661 681
4. G.K. von Schulthess Maximising the benefit of integrated PET/CT: the road ahead Eur J Nucl Med Mol Imaging 31 2004 1462 1463
5. M.W. Groch, and W.D. Erwin SPECT in the year 2000: basic principles J Nucl Med Technol 28 2000 233 244
6. J. Knuuti, H. Minn, and J. Rinne Positron emission tomography: molecular imaging of biological processes in physiology O. Hänninen Encyclopedia of life support systems (EOLSS) 2002 EOLSS Publishers Oxford, England online publication at http://www.eolss.net
7. B. Wall Radiation protection dosimetry for diagnostic radiology patients Radiat Prot Dosim 109 2004 409 419
8. J.B. Bomanji, D.C. Costa, and P.J. Ell Clinical role of positron emission tomography in oncology Lancet Oncol 3 2001 157 164
9. E.M. Rohren, T.G. Turkington, and R.E. Coleman Clinical applications of PET in oncology Radiology 231 2004 305 332
10. P.L. Jager, W. Vaalburg, J. Pruim, E.G.E. de Vries, K-J. Langen, and D.A. Piers Radiolabeled amino acids: basic aspects and clinical applications in oncology J Nucl Med 42 2001 432 445
11. J.M. Hoffman New advances in brain tumour imaging Curr Opin Oncol 13 2001 148 153
12. 123I-iodo-alpha- methyl-l-ptyrosine SPECT in brain tumours J Nucl Med 45 2004 374 381
13. R.J. Gillies, P.A. Schornack, T.W. Secomb, and N. Raghunand Causes and effects of heterogeneous perfusion in tumours Neoplasia 1 1999 197 207
14. A.A. Lammertsma, R.J. Wise, T.C. Cox, D.G. Thomas, and T. Jones Measurement of blood flow, oxygen utilisation, oxygen extraction ratio, and fractional blood volume in human brain tumours and surrounding oedematous tissue Br J Radiol 58 1985 725 734
15. K. Mineura, T. Sasajima, and M. Kowada Perfusion and metabolism in predicting the survival of patients with cerebral gliomas Cancer 73 1994 2386 2394
16. 18F] fluorodeoxyglucose in brain tumours A powerful diagnostic and prognostic tool Invest Radiol 22 1987 360 371
17. B. Kaschten, A. Stevenaert, and B. Sadzot Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine J Nucl Med 39 1998 778 785
18. 11C]methionine PET in patients with low-grade astrocytoma Int J Radiat Oncol Biol Phys 48 2000 43 52
19. JW. Keyes Jr. SUV: standard uptake or silly useless value? J Nucl Med 36 1995 1836 1839
20. R. Hustinx, R. Smith, and F. Bénard Can the standardized uptake value characterize primary brain tumours on FDG-PET? Eur J Nucl Med 26 1999 1501 1509
21. M. Sasaki, Y. Kuwabara, and T. Yoshida A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours Eur J Nucl Med 25 1998 1261 1269
22. A. Del Sole, A. Falini, and L. Racasi Anatomical and biochemical investigation of primary brain tumours Eur J Nucl Med 28 2001 1851 1872
23. 11C-methionine positron emission tomography Cancer 95 2002 1376 1386
24. M.V. Padma, S. Said, and M. Jacobs Prediction of pathology and survival by FDG PET in gliomas J Neurooncol 64 2003 227 237
25. 11C-l-methylmethionine Neurosurgery 40 1997 276 287
26. 11C-methionine PET for differential diagnosis of low-grade gliomas Neurology 50 1998 1316 1322
27. 18F-FDG PET Eur J Nucl Med Mol Imaging 29 2002 176 182
28. O. De Witte, I. Goldberg, and D. Wikler Positron emission tomography with injection of methionine as a prognostic factor in glioma J Neurosurg 95 2001 746 750
29. T. Ogawa, F. Shishido, and I. Kanno Cerebral glioma: evaluation with methionine PET Radiology 186 1993 45 53
30. 11C-methionine and survival in patients with low-grade gliomas Cancer 92 2001 1541 1549
31. 123I]iodo-l-alpha-methyltyrosine uptake and survival in patients with gliomas J Nucl Med 42 2001 1144 1150
32. D. Ribom, A. Smits, M. Hartman, L. Persson, and E. Blomquist On the issue of early and aggressive treatment in grade 2 gliomas J Cancer Res Clin Oncol 129 2003 154 160
33. B. Pirotte, S. Goldman, and P. David Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine Acta Neurochir Suppl (Wien) 68 1997 133 138
34. 18F]fluoro-2-deoxy-d-glucose in the low-grade glioma Neurosurgery 39 1996 470 476
35. R.G. Bittar, A. Olivier, A.F. Sadikot, F. Andermann, G.B. Pike, and D.C. Reutens Presurgical motor and somatosensory cortex mapping with functional magnetic resonance imaging and positron emission tomography J Neurosurg 91 1999 915 921
36. C. Plathow, D. Schulz-Ertner, and C. Thilman Fractionated stereotactic radiotherapy in low-grade astrocytomas: long-term outcome and prognostic factors Int J Radiat Oncol Biol Phys 57 2003 996 1003
37. T. Veninga, H.A. Langendijk, and B.J. Slotman Reirradiation of primary brain tumours: survival, clinical response and prognostic factors Radiother Oncol 59 2001 127 137
38. M.J. van den Bent Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies Semin Oncol 30 Suppl. 19 2003 39 44
39. T.L. Francavilla, R.S. Miletich, G. Di Chiro, N.J. Patronas, H.V. Rizzoli, and D.C. Wright Positron emission tomography in the detection of malignant degeneration of low-grade gliomas Neurosurgery 24 1989 1 5
40. U. Roelcke, K. von Ammon, and O. Hausmann Operated low-grade astrocytomas: a long term PET study on the effect of radiotherapy J Neurol Neurosurg Psychiatry 66 1999 644 647
41. 123I]iodo-alpha-methyl-l-tyrosine and (99m)Tc-MIBI SPET Eur J Nucl Med Mol Imaging 29 2002 1455 1461
42. D. Langleben, and G. Segall PET in differentation of recurrent brain tumour from radiation injury J Nucl Med 41 2000 1861 1867
43. S. Samnick, J.B. Bader, and D. Hellwig Clinical value of iodine-123-alpha-methyl-l-ptyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumour in patients pretreated for glioma at follow-up J Clin Oncol 20 2002 396 404
44. M. Henze, A. Mohammed, and H.P. Schlemmer PET and SPECT for detection of tumour progression in irradiated low-grade astrocytoma: a receiver-operating- characteristic analysis J Nucl Med 45 2004 579 586
45. W.D. Heiss, B. Habedank, and J.C. Klein Metabolic rates in small brain nuclei determined by high-resolution PET J Nucl Med 45 2004 1811 1815
46. H. Zaidi, M.L. Montandon, and D.O. Slosman Magnetic resonance imaging-guided attenuation and scatter corrections in three-dimensional brain positron emission tomography Med Phys 30 2003 937 948
47. 18F]Fluoroethyl) -l-tyrosine and l-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study Eur J Nucl Mech 27 2000 542 549
48. 123I]iodo-l- phenylalanine for routine brain imaging Nucl Med Commun 23 2002 121 130
49. 18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma Eur J Nucl Med Mol Imaging 31 2004 1464 1470
50. 124I]iododeoxyuridine Cancer Res 60 2000 624 635
51. N. Shinoura, M. Nishijima, and T. Hara Brain tumours: detection with C-11 choline PET Radiology 202 1997 497 503
52. 1H-MRS J Neurooncol 62 2003 329 338